The relationship of contextual factors to women's perceptions of medical abortion

Health Care for Women International

Volumn 23, Issue 6-7, 2002, Pages 654-665

  Harvey, S Marie ^a,b   Beckman, Linda J ^b,c   Branch, Meredith Roberts ^a  

^a UNIVERSITY OF OREGON   (United States)

^b Pacific Institute for Women's Health   (United States)

^c ALLIANT INTERNATIONAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTIVE AGENT; MIFEPRISTONE;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE; FEMALE; HUMAN; INDUCED ABORTION; METHODOLOGY; PREGNANCY; PSYCHOLOGICAL ASPECT;

ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADOLESCENT; ADULT; ATTITUDE; FEMALE; HUMANS; MIFEPRISTONE; PREGNANCY;

EID: 11244308221     PISSN: 07399332     EISSN: 10964665     Source Type: Journal    
DOI: 10.1080/07399330290107403     Document Type: Article

References (27)

1. Bachelot, A., Cludy, L., & Spira, A. (1992). Conditions for choosing between drug-induced and surgical abortions. Contraception, 45, 547-549.
2. Beckman, L. J., & Harvey, S. M. (1997). Experience and acceptability of medical abortion with mifepristone and misoprostol among U.S. women. Women's Health Issues, 7(4), 253-262.
3. Berer, M. (1992). Inducing miscarriage: Women centered perspectives on RU 486/prostaglandin as an early abortion method. Law, Medicine and Health Care, 20, 199-208.
4. Clark, S., Ellertson, C., Winikoff, B. (2000). Is medical abortion acceptable to all American women: The impact of sociodemographic characteristics on the acceptability of mifepristone-misoprostol abortion. Journal of the American Medical Women's Association, 55, 177-182.
5. Creinin, M. D., & Edwards, J. (1997). Early abortion: Surgical and medical options. Current Problems in Obstetrics, Gynecology and Fertility, 20(1), 1-32.
6. Creinin, M. D., & Park, M. (1995). Acceptability of medical abortion with methotrexate and misoprostol. Contraception, 52, 41-44.
7. Elul, B., Pearlman, E., Sohaindo, A., Simonds, W., Westhoff, C. (2000). In-depth interviews with medical abortion clients: Thoughts on the method and home administration of misoprostol. Journal of the American Medical Women's Association, 55, 169-172.
8. Harvey, S. M., Beckman, L. J., Castle, M. A., & Coeytaux, F. (1995). Knowledge and perceptions of medical abortion among potential users. Family Planning Perspectives, 27(5), 203-207.
9. Heise, L. L. (1994). Discussion paper on acceptability research. Unpublished discussion paper dated 10/4/94.
10. Heise, L. L. (1997). Beyond acceptability: Reorienting research on contraceptive choice. In T. K. Ravindran, M. Berer, & J. Cottingham (Eds.), Beyond acceptability: User's perspective on contraception (pp. 6-14). London: Reproductive Health Matters for the World Health Organization.
11. Henshaw, S. K., & Van Vort, J. (1994). Abortion services in the United States, 1991 and 1992. Family Planning Perspectives, 26, 100-106 & 112.
12. Henshaw, S. K. (1998). Barriers to access to abortion services. In L. J. Beckman and S. M. Harvey (Eds.), The new civil war: The psychology, culture, and politics of abortion (pp. 61-80). Washington, DC: American Psychological Association.
13. Holmgren, K. (1992). Women's evaluation of three early abortion methods. Acta Obstetricia et Gynecologic a Scandinavica, 71(8), 616-623.
14. Howie, F. L., Henshaw, R. C., Naji, S. A., Russell, I. T., & Templeton, A. A. (1997). Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial. British Journal of Obstetrics and Gynaecology, 104(7), 829-833.
15. Keller, A. (1979). Contraceptive acceptability research: Utility and limitations. Studies in Family Planning, 10(8-9), 375-390.
16. Morgan, D. L. (1997). Focus groups as qualitative research. Thousand Oaks, CA: Sage Publications.
17. Rosen, A. S. (1990). Acceptability of abortion methods. Baillieres Clinical Obstetrics and Gynaecology, 4(2), 375-390.
18. Rosen, A. S., Von Knorring, K., & Bygdeman, M. (1984). Randomized comparison of prostaglandin treatment in hospital or at home with vacuum aspiration for termination of early pregnancy. Contraception, 29, 423-435.
19. Russo, N., Denious, J. (1998). Why is abortion such a controversial issue in the United States? In L. J. Beckman & S. M. Harvey (Eds.), The new civil war: The psychology, culture, and politics of abortion (pp. 25-60). Washington, DC: American Psychological Association.
20. Schaeff, E. A., Eisinger, S. H., Stadalius, L. S., Franks, P., Gore, B. Z., & Poppema, S. (1999). Low-dose mifepristone 200mg and vaginal misoprostol for abortion. Contraception, 59(1), 1-6.
21. Spitz, I. M., Bardin, C. W., Benton, L., & Robbins, A. (1998). Early pregnancy termination with mifepristone and misoprostol in the United States. New England Journal of Medicine, 338(18), 1241-1247.
22. Stanton, A. L., & Danofff-Burg, S. (1995). Selected issues in women's reproductive health: Psychological perspectives. In A. L. Stanton & S. J. Gallent (Eds), The psychology of women's health (pp. 261-305). Washington, DC: American Psychological Association.
23. Tang, G. W. (1991). A pilot study of acceptability of RU 486 and ONO 802 in Chinese population. Contraception, 44, 523-532.
24. Tang, G. W., Lau, O. W. K., & Yip, P. (1993). Further acceptability evaluation of RU 486 and ONO 802 as abortifacient agents in a Chinese population. Contraception, 48, 267-276.
25. Thong, K. J., Dwar, M. H., & Baird, D. T. (1992). What do women want during medical abortion? Contraception, 46, 435-442.
26. Winikoff, B. (1995). Acceptability of medical abortion in early pregnancy. Family Planning Perspectives. 27, 142-148 & 185.
27. Winikoff, B., Ellertson, C., Elul, B., & Sivin, I. (1998). Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Archives of Family Medicine, 7, 360-366.